Welcome to MedArena!

Your trusted destination for CME, CPD & Medical Education across the Middle East.

Information

  • Address:MedArena Corporation
  • Call Us:1 (800) 828-2059
  • Email:support [at] medarenaevents.com
Dr. Ali Ataya

Dr. Ali Ataya

Professor of Medicine & Director of Pulmonary Vascular Disease Center

University of Florida, Gainesville, Florida, USA

About

Dr. Ali Ataya, MD, MBA, ATSF, is an Associate Professor of Medicine in the Division of Pulmonary, Critical Care and Sleep Medicine at the University of Florida (UF) in Gainesville, USA. He specializes in pulmonary hypertension, pulmonary vascular disease, critical care, and rare lung disorders.

Dr. Ataya earned his medical degree (MB, BCh, BAO) from the Royal College of Surgeons in Ireland in 2010, graduating with honors. He completed his Internal Medicine residency at Cleveland Clinic from 2010–2013, followed by a Pulmonary and Critical Care Medicine fellowship at the University of Florida from 2013–2016, where he also served as Chief Fellow. He subsequently pursued specialized training in pulmonary hypertension.

At the University of Florida, Dr. Ataya serves as Director of the Pulmonary Hypertension Center of Comprehensive Care, Director of the Hereditary Hemorrhagic Telangiectasia (HHT) Center of Excellence, and Director of the LAM & Rare Lung Disease Program. His clinical and research interests include pulmonary arterial hypertension, pulmonary alveolar proteinosis, lymphangioleiomyomatosis (LAM), HHT, and other rare pulmonary diseases.

He is also an active researcher and medical educator, with more than 300 publications and research contributions listed in his academic profile. His work has appeared in major respiratory and critical-care journals, including the American Journal of Respiratory and Critical Care Medicine and CHEST.

Position: Associate Professor of Medicine

Division: Pulmonary, Critical Care & Sleep Medicine

Specialty: Pulmonary & Critical Care Medicine

Areas of Expertise: Pulmonary Hypertension, Pulmonary Vascular Disease, Rare Lung Diseases, Critical Care, HHT, LAM, Pulmonary Alveolar Proteinosis

Qualifications: MD, MBA, ATSF

Events & Activities

2nd Cleveland Clinic Abu Dhabi Advances in Lung Disease Conference 2026
Oct 2, 2026
In-Person

2nd Cleveland Clinic Abu Dhabi Advances in Lung Disease Conference 2026

Pearl Event Management Services (PEMS)

  • CME
  • P1 Auditorium, Cleveland Clinic Abu Dhabi, Abu Dhabi, United Arab Emirates
Oct 2, 2026
In-Person

2nd Cleveland Clinic Abu Dhabi Advances in Lung Disease Conference 2026

Free

The 2nd Cleveland Clinic Abu Dhabi Advances in Lung Disease Conference 2026 is a comprehensive scientific conference focused on the latest advances in pulmonary and respiratory medicine. The program will cover key areas including airway diseases, interstitial lung disease, pulmonary hypertension, lung cancer, interventional pulmonology, sleep medicine, and lung transplantation. Through expert-led lectures, symposia, research presentations, and interactive case discussions, participants will gain practical, evidence-based insights to enhance the diagnosis and management of complex lung diseases and improve patient outcomes.

Pearl Event Management Services (PEMS)

  • 2 Days
  • P1 Auditorium, Cleveland Clinic Abu Dhabi, Abu Dhabi, United Arab Emirates
CME Certified Courses
Medical Education Hub
Expert Medical Speakers
AI-Powered Learning
Accredited Certificates
Live Medical Events
Continuous Medical Education
CME Certified Courses
Medical Education Hub
Expert Medical Speakers
AI-Powered Learning
Accredited Certificates
Live Medical Events
Continuous Medical Education
CME Certified Courses
Medical Education Hub
Expert Medical Speakers
AI-Powered Learning
Accredited Certificates
Live Medical Events
Continuous Medical Education